American Oncology Network, Inc. (AONC)
NASDAQ: AONC · IEX Real-Time Price · USD
3.850
+0.030 (0.79%)
May 1, 2024, 4:00 PM EDT - Market closed
American Oncology Network Market Cap
American Oncology Network has a market cap or net worth of $40.84 million as of May 2, 2024. Its market cap has decreased by -60.85% in one year.
Market Cap
40.84M
Enterprise Value
102.44M
1-Year Change
-60.85%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since March 10, 2021, American Oncology Network's market cap has decreased from $312.50M to $40.84M, a decrease of -86.93%. That is a compound annual growth rate of -47.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2024 | 136.40M | -12.79% |
Apr 29, 2024 | 156.40M | 9.37% |
Apr 26, 2024 | 143.00M | 2.95% |
Apr 25, 2024 | 138.90M | -15.46% |
Apr 24, 2024 | 164.30M | -4.14% |
Apr 23, 2024 | 171.40M | -0.46% |
Apr 22, 2024 | 172.20M | -1.20% |
Apr 19, 2024 | 174.30M | 7.99% |
Apr 18, 2024 | 161.40M | -15.23% |
Apr 17, 2024 | 190.40M | -1.09% |
Apr 16, 2024 | 192.50M | 5.25% |
Apr 15, 2024 | 182.90M | -7.91% |
Apr 12, 2024 | 198.60M | 1.48% |
Apr 11, 2024 | 195.70M | 3.60% |
Apr 10, 2024 | 188.90M | -4.21% |
Apr 9, 2024 | 197.20M | 1.28% |
Apr 8, 2024 | 194.70M | 0.41% |
Apr 5, 2024 | 193.90M | - |
Apr 4, 2024 | 193.90M | -0.92% |
Apr 3, 2024 | 195.70M | -3.02% |
Apr 2, 2024 | 201.80M | 0.20% |
Apr 1, 2024 | 201.40M | 2.70% |
Mar 28, 2024 | 196.10M | -4.11% |
Mar 27, 2024 | 204.50M | -1.16% |
Mar 26, 2024 | 206.90M | 1.17% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lucid Diagnostics | 42.39M |
Incannex Healthcare | 42.37M |
Cyclo Therapeutics | 41.64M |
Cara Therapeutics | 41.47M |
Bright Green | 41.19M |
Ocuphire Pharma | 40.69M |
ReWalk Robotics | 40.36M |
Xilio Therapeutics | 39.87M |